(*shared first authorship)

Weber WA, Czernin J, Anderson CJ, Badawi RD, Barthel H, Bengel F, Bodei L, Buvat I, DiCarli M, Graham MM, Grimm J, Herrmann K, Kostakoglu L, Lewis JS, Mankoff DA, Peterson TE, Schelbert H, Schöder H, Siegel BA, Strauss HW. (2020) The Future of Nuclear Medicine, Molecular Imaging, and Theranostics. J Nucl Med. 2020 Dec;61(Suppl 2):263S-272S. doi: 10.2967/jnumed.120.254532.

Roberts S, Khera E, Choi C, Navaratna T, Grimm J, Thurber GM, Reiner T. (2020) Optoacoustic imaging of Glucagon-like Peptide 1 Receptor with a near-infrared exendin-4 analog. J Nucl Med. 2020 Oct 23:jnumed.120.252262. doi: 10.2967/jnumed.120.252262.

Grimm J. (2020) Insights Into Drug Development Using Nanotechnology. Clin Adv Hematol Oncol. 2020 Jul;18(7):379-381.

Grimm J, Kiessling F, Pichler BJ. (2020) Quo Vadis, Molecular Imaging? J Nucl Med. 2020 Oct;61(10):1428-1434. doi: 10.2967/jnumed.120.241984. Epub 2020 Aug 28. PMID: 32859706 Grimm J. (2020) Insights into Drug Development Using Nanotechnology. Clin Adv Hematol Oncol. 2020 Jul;18(7):379-381.

Pratt EC, Isaac E, Stater E, Yang G, Ouerfelli O, Pillarsetty NVK, Grimm J. (2020) Synthesis of novel PET tracer 124I-trametinib for MAPK/ERK kinase distribution and resistance monitoring. J Nucl Med. 2020 May 22:jnumed.120.241901. doi: 10.2967/jnumed.120.241901.

Haedicke K, Agemy L, Omar M, Berezhnoi A, Roberts S, Longo-Machado C, Skubal M, Nagar K, Hsu HT, Kim K, Reiner T, Coleman J, Ntziachristos V, Scherz A, Grimm J. (2020) High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies. Nat Biomed Eng. 2020 Mar;4(3):286-297. doi: 10.1038/s41551-020-0527-8. Epub 2020 Mar 12.

Mueller JJ, Dauer LT, Murali R, Iasonos A, Pandit-Taskar N, Abu-Rustum N, Grimm J. Positron lymphography viaintracervical 18F-FDG injection for pre-surgical lymphatic mapping in cervical and endometrial malignancies. J Nucl Med. 2020 Jan 10. pii: jnumed.119.230714. doi: 10.2967/jnumed.119.230714. 

Alvim R, Nagar K, Das S, Lebdai S, Wong N, Somma A, Hughes C, Thomas J, Monette S, Scherz A, Kim K, Grimm J, Coleman JA. PositronEmission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model. Eur Urol Focus. 2019 Jun 18. pii: S2405-4569(19)30163-4. doi: 10.1016/j.euf.2019.06.008. 

Roberts S, Storme A, Choi C, Andreou C, Kossatz S, Brand C, Williams T, Bradbury M, Kircher M, Reshetnyak YK, Grimm J, Lewis JS, Reiner T. Acid specific dark quencher QC1 pHLIP for multi-spectral optoacoustic diagnoses of breast cancer. Scientific Reports. 2019 Jun 12. Article number: 8550. https://doi.org/10.1038/s41598-019-44873-1

Grimm J. High-resolution Cherenkov tomography invivo. Nat Biomed Eng. 2018 Apr;2(4):205-206. doi: 10.1038/s41551-018-0225-y.

Trujillo-Alonso V, Pratt EC, Zong H,Lara-Martinez A, Kaittanis C, Rabie MO, Longo V, Becker MW, Roboz GJ, Grimm J, Guzman ML. FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels. Nat Nanotechnol. 2019 Jun;14(6):616-622. doi: 10.1038/s41565-019-0406-1.

Tamura R, Balabanova A, Frakes SA, Bargmann A, Grimm J, Koch TH, Yin H. Photoactivatable Prodrug of Doxazolidine Targeting Exosomes. J Med Chem. 2019 Feb28;62(4):1959-1970. doi: 10.1021/acs.jmedchem.8b01508.

Tamura R, Pratt EC, Grimm J. Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging. Seminars inNuclear Medicine. Semin Nucl Med. 2018 Jul;48(4):359-366. doi: 10.1053/j.semnuclmed.2018.02.007.

Pratt EC, Shaffer TM, Zhang Q, Drain CM, Grimm J. Nanoparticles as multimodal photon transducers of ionizing
radiation. Nat Nanotechnol. 2018 May;13(5):418-426. doi:10.1038/s41565-018-0086-2.

Roberts S, Andreou C, Choi C, Donabedian P, Jayaraman M, Pratt EC, Tang J, Perez-Medina C, Jason De La CruzM, Mulder WJM, Grimm J, Kircher M, Reiner T. Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer. Chem Sci. 2018 May 18;9(25):5646-5657. doi: 10.1039/c8sc01706a.

Grimm J. High-resolution Cherenkov tomography in vivo. Nat Biomed Eng.2018 Apr. doi: 10.1038/s41551-018-0225-y.

Das S, Haedicke K, Grimm J. Cerenkov-activatedsticky tag for in vivo fluorescence imaging. J Nucl Med. 2018 Jan;59(1):58-65. doi: 10.2967/jnumed.117.198549.

Kaittanis C, Andreou C, Hieronymus H, Mao N, Foss CA, Eiber M,
Weirich G, Panchal P, Gopalan A, Zurita J, Achilefu S, Chiosis G, Ponomarev V,Schwaiger M, Carver BS, Pomper MG, Grimm J. Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. J Exp Med. 2018 Jan 2;215(1):159-175.

Silverman JR, Zhang Q, Pramanik NB, Samateh M, Shaffer TM, Sagiri
SS, Grimm J, John G.Radiation-Responsive Esculin-Derived Molecular Gels as Signal Enhancers for Optical Imaging. ACS Appl Mater Interfaces. 2017 Dec 13;9(49):43197-43204.

Kaittanis C, Bolaender A, Yoo B, Shah N, Ouerfelli O, Grimm J. Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific MolecularInflection Points. Nano Lett. 2017 Nov 8;17(11):7160-7168.

Lockau HH, Neuschmelting V, Ogirala A, VilasecaA, Grimm J. Dynamic 18FFDG PET- Lymphography for in Vivo Identification of Lymph Node Metastases in Murine Melanoma. J Nucl Med. 2017 Sep, jnumed.117.196303.

Flores O, Santra S, Kaittanis C, Bassionuni R, Khaled AR, Grimm J, Perez JM. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer. Theranostics. 2017,24;7(9):2477-2494.

Heckert B, Banerjee T, Sulthana S, Naz S, Alnasser R, Thompson D,
Normand G, Grimm J, Perez JM, SantraS. Design and Synthesis of New Sulfur-Containing Hyperbranched Polymer and Theranostic Nanomaterials for Bimodal Imaging and Treatment of Cancer. ACS Macro Lett. 2017, 6 (3): pp 235-240.

Haedicke K, Brand C, Omar M, Ntziachristos V, Reiner T, Grimm J. Sonophore labeled RGD: a targeted contrast agent for optoacoustic imaging.Photoacoustics. eCollection. 2017 Mar 21;6:1-8. doi: 10.1016/j.pacs.2017.03.001. 

Zhao Y, Shaffer TM, Das S, Pérez-Medina C, Mulder WJ, Grimm J. Near-Infrared Quantum Dot and 89Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov Imaging. BioconjugChem. 2017 Feb 15;28(2):600-608.

Büchel GE, Carney B, Shaffer TM, Tang J, Austin C, Arora M, Zeglis
BM, Grimm J, Eppinger J, Reiner T.Near-Infrared Intraoperative Chemiluminescence Imaging. ChemMedChem. 2016 Sep 20; 11(18):1978-82.

Shaffer TM, Harmsen S, Khwaja E, Kircher MF, Drain CM, Grimm J. Stable Radiolabeling of Sulfur-Functionalized Silica Nanoparticles with Copper-64. NanoLett. 2016 Sep 14; 16(9):5601-4.

Neuschmelting V, Lockau H, Ntziachristos V, Grimm J,Kircher MF. Lymph Node Micrometastases and In-Transit Metastases from Melanoma: In Vivo Detection with Multispectral Optoacoustic Imaging in a Mouse Model. Radiology 2016 Jul; 280(1):137-50.

Kaittanis C, ShafferTM, Bolaender A, Appelbaum Z, Appelbaum J,
Chiosis G, Grimm J. MultifunctionalMRI/PET Nanobeacons derived from the in Situ Self-Assembly of translational polymers and clinical cargo through coalescent intermolecular forces. Nano Let 2015 Dec 9; 15(12): 8032-43.

Vargas HA, Grimm J, F Donati O, Sala E, Hricak H. Molecular imaging of prostate cancer: translatingmolecular biology approaches into the clinical realm. Eur Radiol. 2015 May; 25(5):1294-302.

Lohrmann C, Zhang H, Thorek DL, Desai P, Zanzonico PB, O'Donoghue J, Irwin CP, Reiner T, Grimm J,Weber WA. Cerenkov Luminescence Imaging for Radiation Dose Calculation of a 90Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist. J Nucl Med. 2015 May; 56(5):805-11.

Grimm J. Cancer nanomedicine: Therapy for within. Nat Nanotechnol 2015Apr; 10(4):299-300.

Shaffer TM, Wall MA, Harmsen S, Longo VA, Drain CM, Kircher MF, Grimm J. Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. Nanoletters2015 Feb 11; 15(2):864-8. 

Thorek DJ, Das S, Grimm J. Molecular imaging using nanoparticle quenchers of Cerenkov luminescence. Small2014; 10(18): 3729-34.

Kaittanis C, Shaffer TM, Ogirala A, Santra S, Perez JM, Chiosis G,
Li Y, Josephson L, Grimm J.Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching. Nat Commun. 2014; 5:3384.

Thorek DL, Ulmert D, Ndeye-Fatou M. Diop NFM, Lupu ME, Doran MG, Huang R, Abou DS, Larson SM, Grimm J.Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MR nanoparticle. Nat Commun. 2014; 5:3097.

Thorek DL, Riedl CC, Grimm J. Clinical Cerenkov luminescence imaging of (18)F-FDG. J Nucl Med. 2014;55(1):95-8.

Thorek DL, Ogirala A, Beattie BJ, Grimm J. Quantitative imaging of disease signatures through radioactive decay signal conversion. Nat Medicine 2013; (19):1345-50.

Santra S, Jativa SD, Kaittanis C, Normand G, Grimm J, Perez JM. Gadolinium encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent. ACS Nano. 2012; 6(8):7281-94. 

Thorek DL, Abou DS, Beattie BJ, Bartlett RM, Huang R, Zanzonico
PB, Grimm J. Positron lymphography:multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG. J Nucl Med. 2012; 53(9):1438-45.

Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander
NH, Lewis JS, Grimm J. Targeting theinternal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. J Nucl Med. 2011; 52(10):1608-15.

Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-tracking methods. Nat Rev Clin Oncol. 2011;8(11):677-88.

Holland JP, Normand G, Ruggiero A, Lewis JS, Grimm J. Intraoperative imaging of positron emission tomographic
radiotracers using Cerenkov luminescence emissions. Mol Imaging 2011; 10(3):177-86, 1-3.

Ruggiero A, Holland JP, Lewis JS, Grimm J. Cerenkov luminescence imaging of medical isotopes. J Nucl Med. 2010; 51(7):1123-30. 

Kirsch DG, Grimm J, Guimaraes AR, Wojtkiewicz GR, Perez BA, Santiago PM, Anthony NK, Forbes T,Dopke K, Weissleder R, Jacks T. Imaging primary lung cancers in mice to study radiation biology. Int J Radiat Oncol Biol Phys. 2010; 76(4): 973-7.

Santra S, Kaittanis C, Grimm J, Perez JM. Drug/dye-loaded, multifunctional iron oxide nanoparticles forcombined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 2009; 5(16): 1862-8.

Perez JM, Grimm J*, Josephson L, Weissleder R. Integrated nanosensors to determine levels andfunctional activity of human telomerase. Neoplasia 2008; 10(10):1066-72.

Kircher M, Grimm J, Swirski FK, Libby P, Gerszten RE, Allport JR, Weissleder R. Noninvasive in vivoimaging of monocyte trafficking to atherosclerotic lesions. Circulation 2008; 117(3):388-95. 

Pittet MJ, Grimm J*, Berger C, Tamura T, Wojtkiewicz G, Nahrendorf M, Romero P, Swirski FK,Weissleder R. In vivo imaging of Tcell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci USA 2007; 104 (30): 12457-61.

Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, Takeuchi O, Bronson RT, Crowley D, Korsmeyer SJ, Yoon SS, HornicekFJ, Weissleder R, Jacks T. A Spatially and Temporally-Restricted Mouse Model of Soft Tissue Sarcoma. Nat Med 2007; 13(8):992-7.

Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleider, R, Jacks T. Restoration of p53 function leads to tumorregression in vivo. Nature 2007; 445: 661-5.

Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD.Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity. J Immunol. 2006; 177 (10):6991-8.

Tannos B, Grimm J*, Perry JF, Chen JW, Weissleder R, Breakfield S. Metabolic biotinylation of cellsurface receptors for in vivo imaging. Nat Methods 2006; 3(5):391-6.

Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R. An X-ray computed tomography imaging agentbased on long-circulating bismuth sulphide nanoparticles. Nat Mater. 2006; 5(2):118-22.

Kim CF, Jackson EL, Kirsch DG, Grimm J, Shaw AT, Lane K, Kissil J, Olive KP, Sweet-Cordero A, Weissleder R, Jacks T. Mouse models of human non-small-cell lung cancer:raising the bar. Cold Spring Harb Symp Quant Biol. 2005; 70:241-50.

Zacharakis G, Kambara H, Shih H, Ripoll J, Grimm J, Saeki Y, Weissleder R, Ntziachristos V. Volumetric tomography
of fluorescent proteins through small animals in-vivo. Proc Nat Acad Science.2005; 102 (51): 18252-57.

Grimm J*, Kirsch DG, Windsor SD, Kim CF, Santiago PM, Ntziachristos V, Jacks T, Weissleder R. Use of Gene Expression Profiling to Direct In Vivo Molecular Imaging of Lung Cancer. Proc Natl Acad Sci USA. 2005; 102(40): 14404-09.

Grimm J, Perez M, Josephson L, Weissleder R. Novel nanosensors for rapiddetection of telomerase activity. Cancer Research. 2004; 64: 639-43.

Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8+ T-cells to thepancreas in real time. Diabetes. 2004; 53(6): 1459-66.

Grimm J, Potthast A, Wunder A, Moore A. Magnetic resonance imaging of thepancreas and pancreatic tumors in a mouse orthotopic model of human Cancer. Int J Cancer. 2003; 106: 806-11.

Muller-Hulsbeck S, Dimitte DN, Jahnke T, Hedderich J, Grimm J, Heller M. [In-vitro comparison of the effectiveness of different high-speed rotatory catheters]. Rofo. 2003;175(3): 406-12.

Muller-Hulsbeck S, Jahnke T, Liess C, Glass C, Grimm J, Heller M. Comparison of various cerebral protection devices used for carotid artery stent placement: anin vitro experiment. J Vasc Interv Radiol. 2003; 14(5): 613-20.

Mohr A, Priebe M, Taouli B, Grimm J, Heller M, Brossmann J. Selective water excitation for faster MR imagingof articular cartilage defects: initial clinical results. Eur Radiol 2003; 13(4): 686-9.

Grimm J, Brunn H, Heller M, Mueller-Huelsbeck S. Hemolytic effect ofdeformed intra-arterial stents and stent grafts in vitro.  Eur Radiol 2003; 13(6): 1333-8.

Grimm J, Jahnke T, Muhle C, Heller M, Muller-Hulsbeck S. Influence ofThrombus Age on the Mechanical Thrombectomy Efficacy of the Amplatz Thrombectomy Device In Vitro. Cardiovasc Intervent Radiol 2003; 26(3): 265-8.

Both M, Jahnke T, Reinhold-Keller E, Reuter M, Grimm J, Biederer J, Brossmann J, Gross WL, Heller M, Mueller-Huelsbeck S. Percutaneous management of occlusivearterial disease associated with vasculitis: a single center experience. Cardiovasc Intervent Radiol. 2003; 26(1): 19-26.

Oudkerk M, Torres CG, Song B, Konig M, Grimm J, Fernandez-Cuadrado J, Op de Beeck B, Marquardt M, van Dijk
P, de Groot JC. Characterization of liver lesions with mangafodipirtrisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology. 2002; 223(2): 517-24.

Muller-Hulsbeck S, Grimm J, Leidt J, Heller M. In vitro effectiveness of mechanical thrombectomy devicesfor large vessel diameter and low-pressure fluid dynamic applications. J Vasc Interv Radiol. 2002; 13(8): 831-9.

Muller-Hulsbeck S, Grimm J, Liess C, Hedderich J, Bergmeyer M, Heller M. Comparison and modification of twocerebral protection devices used for carotid angioplasty: in vitro experiment. Radiology. 2002; 225(1): 289-94.

Muller-Hulsbeck S, Jahnke T, Liess C, Glass C, Paulsen F, Grimm J, Heller M. In vitro comparison of four cerebral protection filters for preventing human plaque embolizationduring carotid interventions. J Endovasc Ther. 2002; 9(6): 793-802.

Muller-Hulsbeck S, Walluscheck KP, Priebe M, Grimm J, Cremer J, Heller M. Experience on endothelial cell adhesion on vascular stents and stent-grafts: first in vitro results. InvestRadiol. 2002; 37(6): 314-20.

Muller-Hulsbeck S, Jahnke T, Grimm
J, Behm C, Hilbert C, Frahm C, Biederer J, Brossmann J, Heller M. [Earlyresults with a monorail-stent-balloon device for endovascular treatment of renal artery stenosis]. Rofo. 2002; 174(3): 335- 41.

Muhle C, Brossmann J, Biederer J, Jahnke T, Grimm J, Heller M. [Alar ligaments: radiological aspects in the diagnosis of patients with whiplash injuries]. Rofo. 2002; 174(4): 416-22.

Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M, Brossmann J. Endovascular placement of self-expanding
nitinol coil stents for the treatment of femoropopliteal obstructive disease. JVasc Interv Radiol. 2002; 13(3): 257-66.

Biederer J, Reuter M, Both M, Muhle C, Grimm J, Graessner J, Heller M. Analysis of artefacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo andT2-weighted fast spin-echo sequences with respiratory triggering. Eur Radiol. 2002; 12(2): 378-84.

Biederer J, Busse I, Grimm J, Reuter M, Muhle C, Freitag S, Heller M. [Sensitivity of MRI in detectingalveolar Infiltrates: Experimental studies]. Rofo. 2002; 174(8): 1033-9.

Priebe M, Paulsen F, Jahnke T, Grimm J, Heller M, Muller-Hulsbeck S. [Mechanical brush-catheter abrasion method for the isolation and culture of human umbilical veinendothelial cells. First in vitro results]. Rofo. 2001; 173(10): 955- 8.

Müller-Hülsbeck S, Grimm J, Jahnke T, Häselbarth G, Heller M. Flow patterns from metallic vascular endoprostheses:in vireo results. Eur Radiol 2001; 11: 893-901.

Müller-Hülsbeck S, Brossmann J, Jahnke T, Grimm J, Reuter M, Bewig B, Heller M. Mechanical thrombectomy of major and massive pulmonary embolism with use of the amplatz thrombectomydevice. Invest Radiol. 2001; 36(6): 317-22.

Muller-Hulsbeck S, Grimm J, Leidt J, Jahnke T, Heller M. Comparison of in vitro effectiveness of mechanicalthrombectomy devices. J Vasc Interv Radiol. 2001; 12(10): 1185-91.

Muhle C, Brossmann J, Biederer J, Grimm J, Mohr A, Heller M. [Value of kinematic MRI in the evaluation of patients with exacerbated pain in cervical spine motion comparedwith static MRI]. Rofo. 2001; 173(2): 126-32.

Jahnke T, Link J, Muller-Hulsbeck S, Grimm J, Heller M, Brossman J. Treatment of infrapopliteal occlusive disease by high-speed rotational atherectomy: initial and mid-termresults. J Vasc Interv Radiol. 2001; 12(2): 221-6.

Grimm J, Muller-Hulsbeck S, Blume J, Biederer J, Heller M. [Comparison ofbiphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions]. Rofo. 2001; 173(3): 266-72.

Grimm J, Muller-Hulsbeck S, Heller M. Comparison of the mechanical thrombectomyefficacy of the Amplatz thrombectomy device and the Cragg thrombolytic brush in vitro. Invest Radiol. 2001; 36(4): 204-9.

Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M.Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001; 12(8): 935-42.

Grimm J, Mueller-Huelsbeck S, Mueller M, Egbers HJ, Brinkmann G, HellerM. Evaluation of hydroxyapatite implants in vertebral bodies and extremities by contrast-enhanced magnetic resonance imaging. Arch Orthop Trauma Surg. 2001; 121(3): 158-61.

Burklein D, Lochmuller E, Kuhn V, Grimm J, Barkmann R, Muller R, Eckstein F. Correlation of thoracic and lumbar vertebral failure loads with in situ vs. ex situ dual energy X-rayabsorptiometry. J Biomech. 2001; 34(5): 579-87.

Müller-Hülsbeck S, Grimm J, Jahnke T, Brossmann J, Hilbert C, Heller M. [First results after implantationof the new balloon-expanded Bridge-Stent into the iliac artery]. Rofo. 2000; 172(10): 836- 41.

Karger N, Biederer J, Lusse S, Grimm J, Steffens J, Heller M, Gluer C. Quantitation of renal perfusion using arterial spin labeling with FAIR- UFLARE. Magn Reson Imaging2000; 18(6): 641-7.

Jahnke T, Brossmann J, Voshage G, Hilbert C, Muller-Hulsbeck S, Grimm J, Toellner D, Heller M. [Mid-term follow-up after placement of the new balloon-expendable VIP-stentinto the iliac arteries]. Rofo. 2000; 172(4): 381-5.

Grimm J, Karger N, Lusse S, Winoto-Morbach S, Krisch B, Muller-HulsbeckS, Heller M. Characterization of ultrasmall magnetite [correction of paramagnetic magnetite] particles as superparamagnetic contrast agents in MRI. Invest Radiol 2000; 35(9): 553-6.

Todriia TV, Drize NI, Chertkov IL, Grimm J, Zander A. [Telomerase activity in the mouse bone marrow and subpopulations of spleen colony-forming units]. Biull Eksp Biol Med. 1999;127(3): 311-3.

Muller-Hulsbeck S, Schwarzenberg H, Tschach T, Grimm J, Heller M. [In vitro comparison of a size 6F and 8F high-speed rotational catheter for mechanical thrombusfragmentation]. Rofo. 1999; 170(1):94-8.

Muller-Hulsbeck S, Bathe M, Grimm J, Heller M. Enhancement of in vitro effectiveness for hydrodynamicthrombectomy devices. Simultaneous high-pressure rt-PA application. Invest Radiol. 1999; 34(8): 536-42.

Muller-Hulsbeck S, Grimm J, Suwelack D, Heller M. Mechanical assistance for enhancement of in vitroeffectiveness for hydrodynamic thrombectomy. Invest Radiol 1999; 34(11): 669-77.

Grimm J, Zeller W, Zander AR. Soluble interleukin-2 receptor serum levels after allogeneic bonemarrow transplantations as a marker for GVHD. Bone Marrow Transplant. 1998; 21(1): 29-32.

Zander AR, Berger C, Kroger N, Stockshlader M, Kruger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schonrock P, Kuse R, BraumannD, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. Clin Cancer Res. 1997; 3(12 Pt 2): 2671-5.

Stockschlader M, Hassan HT, Krog C, Kruger W, Loliger C, Horstman
M, Altnoder M, Clausen J, Grimm J,Kabisch H, Zander A. Long-term follow-up of leukemia patients after related cryopreserved allogeneic bone marrow transplantation.  Br J Haematol. 1997; 96(2): 382-6.

Krueger W, Stockschlader M, Sobottka I, Betker R, De Wit M, Kroger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander AR. Antimycotictherapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation. Leuk Lymphoma. 1997; 24(5-6): 491-9.

Grimm J, Zeller W, Zander AR. Separation and characterization of mobilizedand unmobilized peripheral blood progenitor cells by counterflow centrifugal elutriation. Exp Hematol. 1995; 23(6): 535-44.